Breakthroughs in Atopic Dermatitis, with Linda Stein Gold, MD
- Author
- Medical Economics
- Published
- Sun 09 Mar 2025
- Episode Link
- https://audioboom.com/posts/8666311
Linda Stein Gold, MD, FAAD, discusses the late-breaking tapinarof cream 1% data from a new analysis of the ADORING-3 clinical trial. Interview recorded at the 2025 American Academy of Dermatology conference in Orlando, Florida.
Topics discussed include:
Topics discussed include:
- Key insights from the new analysis of the ADORING-3 clinical trial on the use of tapinarof cream, 1% in patients with atopic dermatitis.
- Long-term safety and efficacy of tapinarof cream.
- How tapinarof cream differs from existing treatment options.
- Impacts on clinical practice.
